Gainers
- Columbia Care CCHWF shares gained 0.58%, closing at $2.93.
- Greenlane Holdings GNLN shares rose 1.2%, to close at $3.36.
- GW Pharmaceuticals GWPH shares gained 1.49%, closing at $111.03 after announcing its recommendation for NHS to cover prescriptions.
- Innovative Industrial IIPR shares rose 2.4%, to close at $81.95 amid the closure of its sale-leaseback transaction with Green Thumb Industries.
- Therapix Biosciences TRPX shares gained 19.44%, closing at $1.72.
- Valens Groworks VGWCF shares rose 4.07%, to close at $2.41.
Losers
- Aurora Cannabis ACB shares fell 0.56% to close at $3.55.
- Aphria APHA shares dropped by 6.11%, to close at $4.46.
- Canopy Growth CGC shares dropped by 3.9%, to close at $18.50.
- Cresco Labs CRLBF shares tumbled by 6.19%, eventually closing at $5.98.
- Cronos Group CRON shares tumbled by 7.15%, eventually closing at $7.27.
- CannTrust Holdings CTST shares fell 0.62% to close at $0.97.
- Fire & Flower Holdings FFLWF shares dropped by 5.91%, to close at $0.64.
- HEXO HEXO shares fell 6.6% to close at $1.98.
- Harvest Health HRVSF shares tumbled by 2.86%, eventually closing at $2.72.
- Akerna KERN shares fell 7.69% to close at $3.60.
- KushCo Holdings KSHB shares tumbled by 5.82%, eventually closing at $1.62.
- MediPharm Labs MEDIF shares tumbled by 1.52%, eventually closing at $3.28.
- MedMen Enterprises MMNFF shares dropped by 3.3%, to close at $1.02.
- OrganiGram Holdings OGI shares fell 8.06% to close at $2.51.
- Planet 13 Holdings PLNHF shares fell 2.09% to close at $1.62.
- Pyxus International PYX shares tumbled by 9.17%, eventually closing at $9.21.
- Sundial Growers SNDL shares dropped by 5.25%, to close at $3.61.
- Supreme Cannabis Co SPRWF shares dropped by 10.17%, to close at $0.59.
- Tilray TLRY shares fell 2.97% to close at $20.93.
- cbdMD YCBD shares fell 1.84% to close at $3.74.
- Zynerba Pharmaceuticals ZYNE shares tumbled by 1.84%, eventually closing at $6.41.
Related Links:
Meet Her Highness, The New Female-Forward Cannabis Brand
Charlotte's Web Trades Down After Reporting $1.3M Q3 Net Loss, Increases In E-Commerce, Retail Sales
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.